Ohkura Yu, Haruta Shusuke, Shindoh Junichi, Tanaka Tsuyoshi, Ueno Masaki, Udagawa Harushi
Departments of Gastroenterological Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
World J Surg Oncol. 2017 May 25;15(1):106. doi: 10.1186/s12957-017-1173-9.
For proximal gastric cancer invading the greater curvature, concomitant splenectomy is frequently performed to secure the clearance of lymph node metastases. However, prognostic impact of prophylactic splenectomy remains unclear. The aim of this study was to clarify the oncological significance of prophylactic splenectomy for advanced proximal gastric cancer invading the greater curvature.
Retrospective review of 108 patients who underwent total or subtotal gastrectomy for advanced proximal gastric cancer involving the greater curvature was performed. Short-term and long-term outcomes were compared between the patients who underwent splenectomy (n = 63) and those who did not (n = 45).
Patients who underwent splenectomy showed higher amount of blood loss (538 vs. 450 mL, p = 0.016) and morbidity rate (30.2 vs. 13.3, p = 0.041) compared with those who did not undergo splenectomy. In particular, pancreas-related complications were frequently observed among patients who received splenectomy (17.4 vs. 0%, p = 0.003). However, no significant improvement of long-term outcomes were confirmed in the cases with splenectomy (5-year recurrence-free rate, 60.2 vs. 67.3%; p = 0.609 and 5-year overall survival rates, 63.7 vs. 73.6%; p = 0.769). On the other hand, splenectomy was correlated with marginally better survival in patients with Borrmann type 1 or 2 gastric cancer (p = 0.072).
For advanced proximal gastric cancer involving the greater curvature, prophylactic splenectomy may have no significant prognostic impact despite the increased morbidity rate after surgery. Such surgical procedure should be avoided as long as lymph node involvement is not evident.
对于侵犯大弯侧的近端胃癌,常进行脾切除术以确保清除淋巴结转移灶。然而,预防性脾切除术对预后的影响仍不明确。本研究的目的是阐明预防性脾切除术对侵犯大弯侧的进展期近端胃癌的肿瘤学意义。
对108例行全胃或次全胃切除术治疗侵犯大弯侧的进展期近端胃癌患者进行回顾性分析。比较行脾切除术的患者(n = 63)和未行脾切除术的患者(n = 45)的短期和长期结局。
与未行脾切除术的患者相比,行脾切除术的患者失血量更多(538 vs. 450 mL,p = 0.016),发病率更高(30.2 vs. 13.3,p = 0.041)。特别是,在接受脾切除术的患者中经常观察到胰腺相关并发症(17.4 vs. 0%,p = 0.003)。然而,脾切除术患者的长期结局未得到显著改善(5年无复发生存率,60.2 vs. 67.3%;p = 0.609;5年总生存率,63.7 vs. 73.6%;p = 0.769)。另一方面,脾切除术与Borrmann 1型或2型胃癌患者的生存略有改善相关(p = 0.072)。
对于侵犯大弯侧的进展期近端胃癌,尽管手术后发病率增加,但预防性脾切除术可能对预后无显著影响。只要没有明显的淋巴结受累,就应避免这种手术。